Navigation Links
Sangamo BioSciences Reports Third Quarter 2009 Financial Results
Date:11/4/2009

e timing of initiation and completion of clinical trials, whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics, and the ability to establish strategic partnerships. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable ZFP-based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in Sangamo's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

    SELECTED CONSOLIDATED FINANCIAL DATA
    (in thousands, except per share data)
    (unaudited)

    STATEMENT OF OPERATIONS DATA:

                                    Three Months Ended      Nine Months Ended
                                        September 30,         September 30,
                                      ----------------      ----------------
                                      2009        2008      2009        2008
                                      ----        ----      ----        ----

    Revenues
      Collaboration agreements      $4,012      $3,196   $11,382      $7,658
      Research grants                   51         549       564       1,694
                                        --         ---       ---       -----
        Total revenues               4,063       3,745    11,946       9,352

    Operating expenses:
      Research and development       6,166       7,563    20,299      24,492
      General and administrative     2,701       2,564     8,634       8,036
        Total operating expenses     8,867      10,127    28,933      32,528
                                
'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
3. Sangamo BioSciences Reports First Quarter 2009 Financial Results
4. Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
5. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
6. Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
7. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
8. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
9. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
10. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
11. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... ... Spa industries, announces the return of its complimentary educational webinar series ... medical business leaders creates success for their clients through targeted marketing, sales, digital ...
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... , ... doTERRA, the leading global essential oils company, is pleased to announce ... the position as Director of the Hinckley Institute at the University of Utah, a ... Jowers states that he was ready for a new challenge, and out of many ...
(Date:7/6/2015)... ... ... Seedstock today announced Pierre Sleiman, founder and CEO of Go Green ... Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 San ... will explore solutions and methodologies that small farmers and entrepreneurs are developing to improve ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
... new research, Atkins diet-low carbohydrate diet can increase the risks ... the production of a fatty acid in the gut , ... acid butyrate, which protects against colorectal cancer, is produced by ... Rowett Research Institute, in Aberdeen, found that the widely ...
... the rule themselves - and certainly so when it comes ... local authorities have sent notices to the Delhi High Court, ... for breeding mosquitoes, the carrier of the dreaded dengue and ... field visits they have found mosquito breeding grounds in the ...
... launching Stop AIDS in Children, a campaign that calls for ... half a million new infant HIV infections that occur worldwide ... the leaders of the world's eight most powerful countries had ... for prevention of mother-to-child transmission (PMTCT) services in the developing ...
... The British government took a step Wednesday toward offering vaccinations ... a measure that could be carried out by late next ... recommended the use of vaccines to guard against the human ... cases of cervical cancer. ,The Department of Health ...
... her current rehab stint pretty 'serious' and doesn't want to 'mess ... Girls' star said that the actress will be in the rehab ... time frame for her stay due to her work schedule. ... We don't know how much longer because of her work schedule, ...
... dozens of nurses who had blocked a main road in front ... The nurses had set up camp in the street in ... ,An AFP reporter saw several units of police in ... security forces cleared the street itself, the nurses managed to continue ...
Cached Medicine News:Health News:Notice Sent to Courts Asking Them to Stop Courting Mosquitoes 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2Health News:Polish Police Break Up Nurses' Pay Protest 2
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
(Date:7/6/2015)... , July 6, 2015 Hologic, Inc. (NASDAQ: ... to release its financial results for the third quarter ... the market closes.  In conjunction with the release, management ... p.m. Eastern Time. Interested participants may listen ... the United States ) or 719-325-4804 (for international ...
(Date:7/6/2015)... N.J. and FARMINGTON, Conn. ... Inc. (NYSE MKT: PTN), a biopharmaceutical company developing ... diseases with significant unmet medical need and commercial ... a private placement of Series E warrants to ... Series F warrants to purchase 2,191,781 shares of ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories ... and Drug Administration (FDA) has approved Absorica™, a novel, ... the treatment of severe recalcitrant nodular acne. Through a ... RLI is expected to launch Absorica™ in the U.S. ...
... 2012  Janssen Therapeutics, Division of Janssen Products, LP, ... (FDA) has issued a Complete Response letter for ... 800mg tablet of PREZISTA® (darunavir). PREZISTA is ... 400mg tablets -- for the treatment of human immunodeficiency ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 3FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 4FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 5FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 6FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 7
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: